**Core Concept**
Mycobacterium leprae is a slow-growing bacterium responsible for leprosy. The treatment of leprosy requires a combination of antibiotics to ensure effective bactericidal activity. The choice of drug is crucial in managing the disease, especially in its early stages.

**Why the Correct Answer is Right**
The most rapidly bactericidal drug for M. leprae is rifampicin. This is because rifampicin inhibits bacterial RNA synthesis by binding to the beta-subunit of RNA polymerase, thereby preventing the transcription of essential bacterial genes. This mechanism of action results in rapid killing of M. leprae, making rifampicin a crucial component of leprosy treatment regimens.

**Why Each Wrong Option is Incorrect**
**Option A:** Isoniazid is a first-line antitubercular agent that targets M. tuberculosis, not M. leprae. While isoniazid has bactericidal activity against M. tuberculosis, it is not the most effective drug against M. leprae.

**Option B:** Clofazimine is an antimicrobial agent with anti-inflammatory properties, commonly used in the treatment of leprosy. However, it has a slower bactericidal effect compared to rifampicin and is often used in combination with other drugs to manage the disease.

**Option C:** Dapsone is an antibacterial agent that has been used to treat leprosy. However, it has a slower bactericidal effect compared to rifampicin and is often used in combination with other drugs to manage the disease.

**Clinical Pearl / High-Yield Fact**
Rifampicin is a key component of leprosy treatment regimens due to its rapid bactericidal activity against M. leprae. It is essential to use rifampicin in combination with other antibiotics to prevent the development of drug resistance and ensure effective treatment of the disease.

**Correct Answer:** C. Rifampicin